Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Werring

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Human Hypertension|March 4, 2024
Allopurinol and blood pressure variability following ischemic stroke and transient ischemic attack: a secondary analysis of XILO-FISTAlexander S Macdonald, Alex McConnachie, David Alexander Dickie, et al.
Translational Stroke Research|October 20, 2022
A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery AnalysisBen Gaastra, Sheila Alexander, Mark K Bakker, et al.
Eclinicalmedicine|March 3, 2023
Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trialJesse Dawson, Michele Robertson, David Alexander Dickie, et al.
Lancet (London, England)|May 21, 2018
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trialNikola Sprigg, Katie Flaherty, Jason P Appleton, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 28, 2026
Rates and Risk Factors for Major Adverse Cardiovascular and Cerebrovascular Events after stroke due to intracerebral haemorrhage: systematic review and study-level meta-analysisVega Pratiwi Putri, Neshika Samarasekera, Tom James Moullaali, et al.
Health Technology Assessment (Winchester, England)|July 20, 2019
Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCTNikola Sprigg, Katie Flaherty, Jason P Appleton, et al.
Annals of Neurology|February 3, 2018
Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhageDavid J Seiffge, Georg Kägi, Patrik Michel, et al.
JAMA Neurology|August 15, 2022
Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A ReviewHugh S Markus, Wiesje M van Der Flier, Eric E Smith, et al.
The Lancet. Neurology|July 23, 2013
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationJoanna M Wardlaw, Eric E Smith, Geert J Biessels, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Human Hypertension|March 4, 2024
Allopurinol and blood pressure variability following ischemic stroke and transient ischemic attack: a secondary analysis of XILO-FISTAlexander S Macdonald, Alex McConnachie, David Alexander Dickie, et al.
Translational Stroke Research|October 20, 2022
A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery AnalysisBen Gaastra, Sheila Alexander, Mark K Bakker, et al.
Eclinicalmedicine|March 3, 2023
Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trialJesse Dawson, Michele Robertson, David Alexander Dickie, et al.
Lancet (London, England)|May 21, 2018
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trialNikola Sprigg, Katie Flaherty, Jason P Appleton, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 28, 2026
Rates and Risk Factors for Major Adverse Cardiovascular and Cerebrovascular Events after stroke due to intracerebral haemorrhage: systematic review and study-level meta-analysisVega Pratiwi Putri, Neshika Samarasekera, Tom James Moullaali, et al.
Health Technology Assessment (Winchester, England)|July 20, 2019
Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCTNikola Sprigg, Katie Flaherty, Jason P Appleton, et al.
Annals of Neurology|February 3, 2018
Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhageDavid J Seiffge, Georg Kägi, Patrik Michel, et al.
JAMA Neurology|August 15, 2022
Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A ReviewHugh S Markus, Wiesje M van Der Flier, Eric E Smith, et al.
The Lancet. Neurology|July 23, 2013
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationJoanna M Wardlaw, Eric E Smith, Geert J Biessels, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
Pageof 7